182 related articles for article (PubMed ID: 30185768)
1. Rosiglitazone Reduces Apoptosis and Inflammation in Lipopolysaccharide-Induced Human Umbilical Vein Endothelial Cells.
Ji XX; Ji XJ; Li QQ; Lu XX; Luo L
Med Sci Monit; 2018 Sep; 24():6200-6207. PubMed ID: 30185768
[TBL] [Abstract][Full Text] [Related]
2. miR-297 Protects Human Umbilical Vein Endothelial Cells against LPS-Induced Inflammatory Response and Apoptosis.
Yao Y; Jia H; Wang G; Ma Y; Sun W; Li P
Cell Physiol Biochem; 2019; 52(4):696-707. PubMed ID: 30921508
[TBL] [Abstract][Full Text] [Related]
3. MiR-599 regulates LPS-mediated apoptosis and inflammatory responses through the JAK2/STAT3 signalling pathway via targeting ROCK1 in human umbilical vein endothelial cells.
Wang J; Du A; Wang H; Li Y
Clin Exp Pharmacol Physiol; 2020 Aug; 47(8):1420-1428. PubMed ID: 32248560
[TBL] [Abstract][Full Text] [Related]
4. Effects of Citral on Lipopolysaccharide-Induced Inflammation in Human Umbilical Vein Endothelial Cells.
Song Y; Zhao H; Liu J; Fang C; Miao R
Inflammation; 2016 Apr; 39(2):663-71. PubMed ID: 26658749
[TBL] [Abstract][Full Text] [Related]
5. Rosiglitazone, a Peroxisome Proliferator-Activated Receptor (PPAR)-γ Agonist, Attenuates Inflammation Via NF-κB Inhibition in Lipopolysaccharide-Induced Peritonitis.
Zhang YF; Zou XL; Wu J; Yu XQ; Yang X
Inflammation; 2015 Dec; 38(6):2105-15. PubMed ID: 26047949
[TBL] [Abstract][Full Text] [Related]
6. Ang-(1-7) protects HUVECs from high glucose-induced injury and inflammation via inhibition of the JAK2/STAT3 pathway.
Chen J; Zhang W; Xu Q; Zhang J; Chen W; Xu Z; Li C; Wang Z; Zhang Y; Zhen Y; Feng J; Chen J; Chen J
Int J Mol Med; 2018 May; 41(5):2865-2878. PubMed ID: 29484371
[TBL] [Abstract][Full Text] [Related]
7. Acanthoic acid inhibits LPS-induced inflammatory response by activating LXRα in human umbilical vein endothelial cells.
Li Y; Zhang XS; Yu JL
Int Immunopharmacol; 2016 Mar; 32():111-115. PubMed ID: 26803523
[TBL] [Abstract][Full Text] [Related]
8. Biochanin A inhibits lipopolysaccharide-induced inflammation in human umbilical vein endothelial cells.
Ming X; Ding M; Zhai B; Xiao L; Piao T; Liu M
Life Sci; 2015 Sep; 136():36-41. PubMed ID: 26141992
[TBL] [Abstract][Full Text] [Related]
9. Vaspin protects against LPS‑induced ARDS by inhibiting inflammation, apoptosis and reactive oxygen species generation in pulmonary endothelial cells via the Akt/GSK‑3β pathway.
Qi D; Wang D; Zhang C; Tang X; He J; Zhao Y; Deng W; Deng X
Int J Mol Med; 2017 Dec; 40(6):1803-1817. PubMed ID: 29039444
[TBL] [Abstract][Full Text] [Related]
10. Anthocyanin-Rich Sour Cherry Extract Attenuates the Lipopolysaccharide-Induced Endothelial Inflammatory Response.
Biro A; Markovich A; Homoki JR; Szőllősi E; Hegedűs C; Tarapcsák S; Lukács J; Stündl L; Remenyik J
Molecules; 2019 Sep; 24(19):. PubMed ID: 31546579
[TBL] [Abstract][Full Text] [Related]
11. Saikosaponin a inhibits lipopolysaccharide-oxidative stress and inflammation in Human umbilical vein endothelial cells via preventing TLR4 translocation into lipid rafts.
Fu Y; Hu X; Cao Y; Zhang Z; Zhang N
Free Radic Biol Med; 2015 Dec; 89():777-85. PubMed ID: 26475038
[TBL] [Abstract][Full Text] [Related]
12. Astilbin alleviates LPS-induced ARDS by suppressing MAPK signaling pathway and protecting pulmonary endothelial glycocalyx.
Kong G; Huang X; Wang L; Li Y; Sun T; Han S; Zhu W; Ma M; Xu H; Li J; Zhang X; Liu X; Wang X
Int Immunopharmacol; 2016 Jul; 36():51-58. PubMed ID: 27111514
[TBL] [Abstract][Full Text] [Related]
13. Puerarin prevents vascular endothelial injury through suppression of NF-κB activation in LPS-challenged human umbilical vein endothelial cells.
Deng HF; Wang S; Li L; Zhou Q; Guo WB; Wang XL; Liu MD; Liu K; Xiao XZ
Biomed Pharmacother; 2018 Aug; 104():261-267. PubMed ID: 29775893
[TBL] [Abstract][Full Text] [Related]
14. Hyperoside Suppresses Lipopolysaccharide-induced Inflammation and Apoptosis in Human Umbilical Vein Endothelial Cells.
Zhou YQ; Zhao YT; Zhao XY; Liang C; Xu YW; Li L; Liu Y; Yang HB
Curr Med Sci; 2018 Apr; 38(2):222-228. PubMed ID: 30074179
[TBL] [Abstract][Full Text] [Related]
15. Sodium tanshinone IIA sulfonate prevents lipopolysaccharide-induced inflammation via suppressing nuclear factor-κB signaling pathway in human umbilical vein endothelial cells.
Cheng J; Chen T; Li P; Wen J; Pang N; Zhang L; Wang L
Can J Physiol Pharmacol; 2018 Jan; 96(1):26-31. PubMed ID: 28658584
[TBL] [Abstract][Full Text] [Related]
16. HSPA12B inhibits lipopolysaccharide-induced inflammatory response in human umbilical vein endothelial cells.
Wu J; Li X; Huang L; Jiang S; Tu F; Zhang X; Ma H; Li R; Li C; Li Y; Ding Z; Liu L
J Cell Mol Med; 2015 Mar; 19(3):544-54. PubMed ID: 25545050
[TBL] [Abstract][Full Text] [Related]
17. XJP-1, a novel ACEI, with anti-inflammatory properties in HUVECs.
Fu R; Chen Z; Wang Q; Guo Q; Xu J; Wu X
Atherosclerosis; 2011 Nov; 219(1):40-8. PubMed ID: 21803355
[TBL] [Abstract][Full Text] [Related]
18. Procyanidin B2 inhibits lipopolysaccharide‑induced apoptosis by suppressing the Bcl‑2/Bax and NF‑κB signalling pathways in human umbilical vein endothelial cells.
Song DQ; Liu J; Wang F; Li XF; Liu MH; Zhang Z; Cao SS; Jiang X
Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33576443
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of rosiglitazone on lipopolysaccharide-induced inflammation in a murine model and HK-2 cells.
Wang WM; Chen H; Zhong F; Lu Y; Han L; Chen N
Am J Nephrol; 2011; 34(2):152-62. PubMed ID: 21734368
[TBL] [Abstract][Full Text] [Related]
20. Rosiglitazone pretreatment protects against lipopolysaccharide-induced fetal demise through inhibiting placental inflammation.
Bo QL; Chen YH; Yu Z; Fu L; Zhou Y; Zhang GB; Wang H; Zhang ZH; Xu DX
Mol Cell Endocrinol; 2016 Mar; 423():51-9. PubMed ID: 26773728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
